Provectus Biopharmaceuticals, Inc. (PVCT)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Immunotherapy Medicines	557.71K
Immunotherapy Medicines Growth	-43.61%

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
United States	557.71K
United States Growth	-43.61%